. . . . . . . "[Measurement of nasal potential difference (NPD) is increasingly used as diagnostic test for cystic fibrosis (CF) and for in vivo evaluation of treatments aimed at correcting the defective function of the cystic fibrosis transmembrane regulator (CFTR) protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:32+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .